SEGMENT INFORMATION

3 Months Ended

Mar. 31, 2014

Segment Reporting [Abstract]

SEGMENT INFORMATION

SEGMENT INFORMATION

Our business consists of one operating and reportable segment for the development, manufacturing and marketing of disposable devices and implants for select surgical procedures.  The development, manufacturing and other supporting functions, such as regulatory affairs and distribution, are common across our Company.  We organize and manage our sales and marketing functions according to geography and the surgical specialty that typically employs our products.  Most of the Company’s products are used in Sports Medicine or ENT procedures.

Product sales by product area for the periods shown were as follows (in thousands):

	Three months ended March 31, 2014						Three months ended March 31, 2013
	Americas		International		Total Product Sales		Americas		International		Total Product Sales
Sports Medicine	$	40,179	$	23,618	$	63,797	$	38,862	$	20,754	$	59,616
ENT	18,785		5,558		24,343		19,748		5,868		25,616
Other	315		1,523		1,838		503		1,743		2,246
Total product sales	$	59,279	$	30,699	$	89,978	$	59,113	$	28,365	$	87,478

Internationally, the Company markets and supports its products primarily through its subsidiaries and various distributors.  Product sales attributed to geographic areas are based on the country or regional area where the Company’s customer is domiciled.  Product sales by geography for the periods shown were as follows (in thousands):

	Three months ended March 31,
	2014		2013
United States	$	56,773	$	56,908
Non-United States (1)	33,205		30,570
Total product sales	$	89,978	$	87,478

 ___________________________________________

(1) No additional locations are individually significant.

Long-lived assets, net by geography, at the balance sheet dates shown were as follows (in thousands):

	March 31, 2014		December 31, 2013
United States	$	171,716	$	172,360
Non-United States (1)	62,454		63,560
Total long-lived assets	$	234,170	$	235,920

 ___________________________________________

(1) No additional locations are individually significant.